中医辨证施治在盆腔炎患者中的临床效果及安全性  

The clinical effect and safety of treating pelvic inflammation by TCM syndrome differentiation and treatment

作　　者：徐慧英 

机构地区：[1]山东省菏泽市市立医院,山东菏泽274000

出　　处：《中医临床研究》2018年第7期45-46,48,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨中医辨证施治在盆腔炎患者中的临床效果及安全性。方法:取2015年11月-2017年4月医院收治的盆腔炎患者80例,按随机数字法分为对照组(n=40)和观察组(n=40)。对照组采用常规西药治疗,观察组采用中医辨证施治治疗,采用酶联免疫吸附试验测定两组治疗前后炎症细胞因子TNF-α、IL-1β、IL-8水平,比较两组临床疗效及安全性情况。结果:观察组治疗后药物起效时间、治疗时间及治疗成本均短(少)于对照组(P<0.05);两组治疗前后TNF-α、IL-1β、IL-8水平比较差异无统计学意义(P>0.05),观察组治疗后7d TNF-α、IL-1β、IL-8水平均低于对照组(P<0.05);观察组治疗后7d药物不良反应发生率为7.50%,与对照组的15.00%比较差异有统计学意义(P<0.05)。结论:盆腔炎患者采用中医辨证施治效果理想,能降低炎症因子水平,安全性较高,值得推广应用。Objective:To discuss the clinical effect and safety of treating pelvic inflammation by TCM syndrome differentiation and treatment.Methods:80 cases from November 2015 to April 2017 were divided into the control group(n=40)and observation group(n=40)by random digital method.The control group was given conventional western medicine.The observation group was given TCM syndrome differentiation and treatment.Levels of inflammatory cytokines TNF-α,IL-1β,IL-8 between two groups before and after treatment were measured by enzyme-linked immunosorbent.The clinical curative effect and security between two groups were compared.Results:The medicine onset time,treatment time and the cost in the observation group were shorter(or less)than the control group(P<0.05).The levels of TNF-α,IL-1β,IL-8 in the observation group after 7 days were lower than those in the control group.The adverse reaction after 7 days was 7.50%in the observational group and 15.00%in the control group;the difference shows statistically significant(P<0.05).Conclusion:TCM syndrome differentiation and treatment on pelvic inflammation shows ideal effects,can reduce inflammatory factor levels,with high security,and is worth popularizing.

关 键 词：中医辨证施治 盆腔炎 常规西药 酶联免疫吸附试验 安全性 

分 类 号：R711.33[医药卫生—妇产科学]